Zhu M S, Chen J Z, Xu A P
Department of Nephrology, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, Guangzhou, 510120, People's Republic of China.
Int Urol Nephrol. 2014 Oct;46(10):1969-75. doi: 10.1007/s11255-013-0560-6. Epub 2014 Aug 24.
Renal biopsy is a very important diagnostic tool in the evaluation of renal diseases. However, bleeding remains to be one of the most serious complications in this procedure. Many new techniques have been improved to make it safer. The risk factors and predictors of bleeding after percutaneous renal biopsy have been extensively reported in many literatures, and generally speaking, the common risk factors for renal biopsy complications focus on hypertension, high serum creatinine, bleeding diatheses, amyloidosis, advanced age, gender and so on. Our primary purpose of this review is to summarize current measures in recent years literature aiming at minimizing the bleeding complication after the renal biopsy, including the drug application before and after renal biopsy, operation details in percutaneous renal biopsies, nursing and close monitoring after the biopsy and other kinds of biopsy methods.
肾活检是评估肾脏疾病时一项非常重要的诊断工具。然而,出血仍是该操作中最严重的并发症之一。许多新技术已得到改进以使其更安全。经皮肾活检后出血的危险因素和预测因素在许多文献中已有广泛报道,一般来说,肾活检并发症的常见危险因素集中在高血压、高血清肌酐、出血性疾病、淀粉样变性、高龄、性别等方面。本综述的主要目的是总结近年来文献中旨在将肾活检后出血并发症降至最低的当前措施,包括肾活检前后的药物应用、经皮肾活检的操作细节、活检后的护理和密切监测以及其他活检方法。